Page last updated: 2024-10-25

deferoxamine and Anemia

deferoxamine has been researched along with Anemia in 109 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research Excerpts

ExcerptRelevanceReference
"Anemia is a well-defined complication of aluminum overload in chronic dialysis patients which may be present before other manifestations of aluminum toxicity are obvious."7.67The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population. ( Alfrey, AC; Contiguglia, RS; Klein, MH; Miller, NL; Mishell, JL; Molitoris, BA; Seligman, PA; Shapiro, JI; Yuan, B, 1989)
"Improvement of microcytic anemia after deferoxamine treatment is described in eight long-term dialysis patients with high serum aluminum concentration and other clinical signs of aluminum toxicity."7.67Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity. ( Burnatowska-Hledin, M; Dombrouski, J; Mayor, G; Swartz, R, 1987)
"All of 34 patients with untreated hemochromatosis had distinctly elevated values for deferoxamine-chelatable iron."5.26Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. ( Baggenstoss, AH; Baldus, WP; Dickson, ER; Fairbanks, VF, 1978)
"The randomized comparison of deferasirox to deferoxamine for myocardial iron removal in patients with transfusion-dependent anemias (CORDELIA) gave the opportunity to assess relative prevalence and body distribution of iron overload in screened patients."5.20Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study. ( Aydinok, Y; El-Beshlawy, A; Elalfy, M; Habr, D; Kilinç, Y; Pennell, DJ; Piga, A; Porter, JB; Quebe-Fehling, E; Viprakasit, V; Yesilipek, A, 2015)
" Recombinant erythropoietin alfa and darbepoetin alfa have been the mainstay of therapy for treating anemia associated with MDS."3.74The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines. ( Cosler, LE; Ferro, SA; Greenberg, PL; Lyman, GH, 2008)
"The study population consisted of 26 Zambian children < 6 years of age who presented with cerebral malaria to a rural hospital in 1994 and who were treated with quinine for seven days."3.70Prolonged macrophage activation and persistent anaemia in children with complicated malaria. ( Biemba, G; Gordeuk, VR; Mabeza, GF; Thuma, PE; Weiss, G, 1998)
"Anemia is a well-defined complication of aluminum overload in chronic dialysis patients which may be present before other manifestations of aluminum toxicity are obvious."3.67The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population. ( Alfrey, AC; Contiguglia, RS; Klein, MH; Miller, NL; Mishell, JL; Molitoris, BA; Seligman, PA; Shapiro, JI; Yuan, B, 1989)
"Improvement of microcytic anemia after deferoxamine treatment is described in eight long-term dialysis patients with high serum aluminum concentration and other clinical signs of aluminum toxicity."3.67Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity. ( Burnatowska-Hledin, M; Dombrouski, J; Mayor, G; Swartz, R, 1987)
"The iron-chelating agent deferoxamine (DF) was administered as a single dose and also daily over a prolonged period to evaluate availability of storage iron in dogs with induced anemia of inflammatory disease."3.66Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease. ( Farver, TB; Feldman, BF; Kaneko, JJ, 1981)
"Iron overload is characterized by excessive iron deposition and consequent injury and dysfunction of the heart, liver, anterior pituitary, pancreas, and joints."2.44Chelation therapy for iron overload. ( Barton, JC, 2007)
"Deferoxamine has been used effectively in clinical practice for more than 40 years."1.35Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias. ( Ault, P; Jones, K, 2009)
"Here, we discuss a patient with primary myelofibrosis and related transfusion-dependent anemia who received chelation therapy with the once-daily oral iron chelator, deferasirox."1.34Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). ( Alberti, D; Angelucci, E; Deplano, S; Di Tucci, AA; Murru, R; Rabault, B, 2007)
" More frequent dosing and/or a longer duration of HP treatment might produce greater reversal of the Al-induced toxicity and perhaps reveal more adverse effects than seen in this study."1.30Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity. ( Dickey, KM; Fredenburg, AM; Hong, CB; Meurer, KA; Skinner, TL; Yokel, RA, 1997)
" This treatment can enhance erythropoiesis without adverse effects."1.30Low dose desferrioxamine can improve erythropoiesis in iron-overload hemodialysis patients without side effects. ( Chen, JB; Hsu, KT; Lam, KK; Lee, CT; Liao, SC, 1999)
" However, there was no correlation between the serum Al level and the dosage of aluminum hydroxide."1.28Effect of body iron stores on serum aluminum level in hemodialysis patients. ( Huang, CC; Huang, JY; Leu, ML; Lim, PS; Wu, MS, 1992)
" The biochemical evidence of functional iron deficiency and the response to aluminum chelation therapy support the hypothesis that the inhibitory effect of aluminum on erythropoiesis is mediated by the interference of aluminum with the bioavailability of iron."1.28The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment. ( Donnelly, SM; Smith, EK, 1990)
"All of 34 patients with untreated hemochromatosis had distinctly elevated values for deferoxamine-chelatable iron."1.26Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. ( Baggenstoss, AH; Baldus, WP; Dickson, ER; Fairbanks, VF, 1978)

Research

Studies (109)

TimeframeStudies, this research(%)All Research%
pre-199065 (59.63)18.7374
1990's24 (22.02)18.2507
2000's17 (15.60)29.6817
2010's1 (0.92)24.3611
2020's2 (1.83)2.80

Authors

AuthorsStudies
Chen, MY1
Ou, SH1
Chen, NC1
Yin, CH1
Chen, CL1
Aydinok, Y1
Porter, JB2
Piga, A1
Elalfy, M1
El-Beshlawy, A1
Kilinç, Y1
Viprakasit, V1
Yesilipek, A1
Habr, D1
Quebe-Fehling, E1
Pennell, DJ1
Greenberg, PL1
Cosler, LE1
Ferro, SA1
Lyman, GH1
McLeod, C1
Fleeman, N1
Kirkham, J1
Bagust, A1
Boland, A1
Chu, P1
Dickson, R1
Dundar, Y1
Greenhalgh, J1
Modell, B2
Olujohungbe, A1
Telfer, P1
Walley, T1
Yap, J1
O'Connor, C1
Kirby, M1
Guindi, M1
Roberts, EA1
Barbieri, L1
Macrì, A1
Lupia Palmieri, G1
Aurizi, C1
Biolcati, G1
Ault, P1
Jones, K1
Fernandes, JL1
Fabron, A1
Verissimo, M1
Leitch, HA1
Vickars, LM1
Jensen, PD2
Jensen, FT2
Christensen, T2
Nielsen, JL2
Ellegaard, J1
Eiskjaer, H1
Baandrup, U1
REWALD, EF1
WOEHLER, F1
DE VRIES, SI1
GOUDSMIT, R1
SCHRETLEN, ED1
NORMAN, CS1
MARCACCI, M1
CICALA, P1
GUIDONE, M1
NAPPI, L1
DIMARTINO, G1
HILDNER, FJ1
MONTO, RW1
REBUCK, JW1
CARLOS, AG1
SOARES, AD1
REWALD, E1
SCURO, LA1
BROCCIA, G1
DOBRILLA, G1
TAGLIAMONTE, A1
KARSTOFT, H1
HWANG, YF1
BROWN, EB1
VENTURA, S2
BETTI, R1
PALUMBO, R1
SENIN, U1
CAPPELLETTI, M1
COLI, L2
WILKINSON, JF1
MOESCHLIN, S1
SCHNIDER, U1
RICHMOND, J1
ALBAHARY, C1
FIELDING, J1
BANNERMAN, RM1
MALPAS, JS1
WHITE, HC1
GEVIRTZ, NR1
TENDLER, D1
LURINSKY, G1
WASSERMAN, LR1
Franchini, M2
Gandini, G2
Veneri, D1
Aprili, G2
Schmidt, D1
Finke, J1
Kashiwagi, T1
Kurihara, S2
Ambrus, CM1
Stadler, I1
Toumbis, CA1
Stadler, A1
Anthone, S1
Anthone, R1
DeAlarcon, P1
Deshpande, G1
Conway, J1
Vladutiu, AO1
Ambrus, JL1
Barton, JC1
Di Tucci, AA1
Murru, R1
Alberti, D1
Rabault, B1
Deplano, S1
Angelucci, E1
Lawson, AA1
Owen, ET1
Mowat, AG1
Green, R1
Lamon, J1
Curran, D1
North, ML1
Lang, JM1
Bergerat, JP1
Giron, C1
Oberling, F1
Mayer, S1
Giordano, N1
Fioravanti, A1
Sancasciani, S1
Marcolongo, R1
Borghi, C1
Van der Weyden, MB1
Feldman, BF1
Kaneko, JJ1
Farver, TB1
Katz, AJ1
Halliday, JW1
Bassett, ML1
Goch, J1
Birgegård, G1
Danielson, BG1
Wikström, B1
Kozlov, AB1
Ostrachovitch, EA1
Afanas'ev, IB1
Ackrill, P1
Day, JP1
Yaqoob, M1
Ahmad, R1
McClelland, P1
Shivakumar, KA1
Sallomi, DF1
Fahal, IH1
Roberts, NB1
Helliwell, T1
Güngör, T1
Rohrbach, E1
Solem, E1
Kaltwasser, JP1
Kornhuber, B1
Salvarani, C1
Baricchi, R1
Lasagni, D1
Boiardi, L1
Piccinini, R1
Brunati, C1
Macchioni, P1
Portioli, I1
Yokel, RA1
Meurer, KA1
Hong, CB1
Dickey, KM1
Skinner, TL1
Fredenburg, AM1
Jurado, RL1
Biemba, G1
Gordeuk, VR1
Thuma, PE1
Mabeza, GF1
Weiss, G1
Wonke, B1
Aucella, F1
Vigilante, M1
Scalzulli, P1
Musto, P1
Prencipe, M1
Valente, GL1
Carotenuto, M1
Stallone, C1
Lee, CT1
Liao, SC1
Hsu, KT1
Lam, KK1
Chen, JB1
Girelli, D1
Lippi, G1
de Gironcoli, M1
Espósito, BP1
Breuer, W1
Slotki, I1
Cabantchik, ZI1
Pippard, MJ1
Callender, ST1
Weatherall, DJ1
Baldus, WP1
Fairbanks, VF1
Dickson, ER1
Baggenstoss, AH1
Nienhuis, AW1
Delea, C1
Aamodt, R1
Bartter, F1
Anderson, WF1
van Vugt, H1
van Gool, J1
Ladiges, NC1
Boers, W1
Vreugdenhil, G1
Feelders, RA1
Coppens, PJ1
de Leeuw, PW1
Marumo, F1
Huang, JY1
Huang, CC1
Lim, PS1
Wu, MS1
Leu, ML1
Verbeelen, D2
Padovese, P1
Gallieni, M1
Galmozzi, C1
Brancaccio, D1
Lowrey, S1
Casati, S2
Campise, M2
Ponticelli, C2
Castelnovo, C1
Cairo, MS1
Donnelly, SM1
Smith, EK1
Hosokawa, S1
Oyamaguchi, A1
Yoshida, O1
Bia, MJ1
Cooper, K1
Schnall, S1
Duffy, T1
Hendler, E1
Malluche, H1
Solomon, L1
Yuan, B1
Klein, MH1
Contiguglia, RS1
Mishell, JL1
Seligman, PA1
Miller, NL1
Molitoris, BA1
Alfrey, AC1
Shapiro, JI1
Van Wyck, DB1
Stivelman, JC1
Ruiz, J1
Kirlin, LF1
Katz, MA1
Ogden, DA1
de la Serna, FJ1
Praga, M2
Gilsanz, F1
Rodicio, JL2
Ruilope, LM2
Alcazar, JM1
Altmann, P1
Plowman, D1
Marsh, F1
Cunningham, J1
Tielemans, C1
Collart, F1
Wens, R1
Smeyers-Verbeeke, J1
Van Hooff, I1
Dratwa, M1
Abreo, K1
Brown, ST1
Sella, M1
Trapp, G1
Andrés, A1
de la Serna, J1
Nieto, J1
Estenoz, J1
Millet, VG1
Arnaiz, F1
Cuvelier, R1
Deceuninck, P1
Felipe, C1
Rivera, M1
Orofino, L1
Matesanz, R1
Ortuño, J1
Basile, C1
Scatizzi, A1
Grossman, SD1
Smith, LE1
O'Brien, AA1
Moore, DP1
Keogh, JA1
Mostert, LJ1
de Jong, G1
Koster, JF1
van Eijk, HG2
Swartz, R1
Dombrouski, J1
Burnatowska-Hledin, M1
Mayor, G1
Schafer, AI1
Rabinowe, S1
Le Boff, MS1
Bridges, K1
Cheron, RG1
Dluhy, R1
Andreoli, SP1
Dunn, D1
DeMyer, W1
Sherrard, DJ1
Bergstein, JM1
Kanz, L1
Arnold, H1
Löhr, GW1
Cartei, G2
Chisesi, T2
Cazzavillan, M2
Battista, R1
Barbui, T2
Dini, E2
Franchi, F1
Bobeck-Rutsaert, MM1
op den Kelder, AM1
Wiltink, WF1
Leijnse, B1
Stromeyer, G1
Turbina, NS1
Stojcevski, T1
Markovic, V1
Heilmeyer, L1
Harker, LA1
Funk, DD1
Finch, CA1
Hofvander, Y1
Jacobs, A1
Kaye, MD1
Trevett, D1
Cimino, R1
Quattrin, N1
Lee, GR1
Cartwright, GE1
Wintrobe, MM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Trial of Oral Nifedipine for the Treatment of Iron Overload[NCT00712738]Phase 16 participants (Actual)Interventional2008-06-20Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for deferoxamine and Anemia

ArticleYear
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.
    Health technology assessment (Winchester, England), 2009, Volume: 13, Issue:1

    Topics: Anemia; Benzoates; Chronic Disease; Contraindications; Cost-Benefit Analysis; Deferasirox; Deferipro

2009
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Aged; Anemia; Benzoates; Blood Component Transfusion; Chelation Therapy; Combined Modality Therapy;

2009
ADVANCES IN TREATMENT OF DISEASES OF THE BLOOD.
    The Practitioner, 1964, Volume: 193

    Topics: Anemia; Anemia, Aplastic; Anemia, Pernicious; Bone Marrow Transplantation; Deferoxamine; Drug Therap

1964
[Aluminum and iron deposition in dialysis patients].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

    Topics: Aluminum; Aluminum Hydroxide; Anemia; Bone Diseases, Metabolic; Contraindications; Deferoxamine; Dem

2004
Chelation therapy for iron overload.
    Current gastroenterology reports, 2007, Volume: 9, Issue:1

    Topics: Anemia; Anemia, Sickle Cell; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferipron

2007
The use of desferrioximine in dialysis-associated aluminium disease.
    Contributions to nephrology, 1993, Volume: 102

    Topics: Aluminum; Anemia; Bone Diseases; Brain Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Rena

1993
Iron, infections, and anemia of inflammation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:4

    Topics: Anemia; Bacteria; Bacterial Infections; Blood Transfusion; Carrier Proteins; Conalbumin; Deferoxamin

1997
Bone disease in beta-thalassaemia major.
    British journal of haematology, 1998, Volume: 103, Issue:4

    Topics: Anemia; beta-Thalassemia; Bone Diseases; Deferoxamine; Female; Humans; Male; Osteoporosis

1998
Advances in the use of iron-chelating agents for the treatment of iron overload.
    Progress in hematology, 1979, Volume: 11

    Topics: Adolescent; Adult; Anemia; Child; Child, Preschool; Deferoxamine; Female; Ferritins; Heart; Hemochro

1979
Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
    Birth defects original article series, 1976, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Aged; Anemia; Ascorbic Acid; Deferoxamine; Drug Evaluation; Feces; Humans; Iron;

1976
Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction.
    The American journal of pediatric hematology/oncology, 1990,Spring, Volume: 12, Issue:1

    Topics: Anemia; Chelation Therapy; Child; Deferoxamine; Erythrocyte Transfusion; Erythropoietin; Humans; Iro

1990
[Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Problemy gematologii i perelivaniia krovi, 1968, Volume: 13, Issue:7

    Topics: Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Animals; Bile; Child, Preschool; Deferoxamine; Hemo

1968

Trials

7 trials available for deferoxamine and Anemia

ArticleYear
Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
    Blood advances, 2023, 06-27, Volume: 7, Issue:12

    Topics: Anemia; Deferiprone; Deferoxamine; Humans; Iron Chelating Agents; Iron Overload

2023
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.
    European journal of haematology, 2015, Volume: 95, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Child; Deferoxamine; Female; Humans; Iron; Iron

2015
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias.
    Blood, 2003, Jan-01, Volume: 101, Issue:1

    Topics: Adult; Aged; Anemia; Chelation Therapy; Deferoxamine; Female; Humans; Iron; Iron Chelating Agents; I

2003
Clinical trial of desferrioxamine entrapped in red cell ghosts.
    Lancet (London, England), 1980, Aug-16, Volume: 2, Issue:8190

    Topics: Adult; Aged; Anemia; Anemia, Aplastic; Blood Transfusion; Clinical Trials as Topic; Deferoxamine; Er

1980
Treatment of erythropoietin-resistant anaemia with desferrioxamine in patients on haemofiltration.
    European journal of haematology, 1995, Volume: 55, Issue:2

    Topics: Adult; Aged; Anemia; Deferoxamine; Drug Resistance; Erythropoietin; Female; Ferritins; Hemofiltratio

1995
Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients.
    European journal of clinical investigation, 2002, Volume: 32 Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Carbohydrates; Chemistry, Pharmaceutical; Cohort

2002
Improvement in the erythropoiesis of chronic haemodialysis patients with desferrioxamine.
    Lancet (London, England), 1988, May-07, Volume: 1, Issue:8593

    Topics: Adult; Aged; Anemia; Clinical Trials as Topic; Creatinine; Deferoxamine; Erythrocyte Count; Erythroc

1988

Other Studies

90 other studies available for deferoxamine and Anemia

ArticleYear
Aluminum overload in the reverse osmosis dialysis era: does it exist?
    Renal failure, 2022, Volume: 44, Issue:1

    Topics: Alkaline Phosphatase; Aluminum; Aluminum Compounds; Anemia; Calcium; Deferoxamine; Erythropoietin; H

2022
The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:9

    Topics: Anemia; Antineoplastic Agents; Azacitidine; Cost of Illness; Costs and Cost Analysis; Darbepoetin al

2008
Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48, Issue:3

    Topics: Adolescent; Anemia; Antiviral Agents; Chelation Therapy; Deferoxamine; Ferritins; Hemoglobinopathies

2009
Association between porphyria cutanea tarda and beta-thalassemia major.
    Cellular and molecular biology (Noisy-le-Grand, France), 2009, Jul-01, Volume: 55, Issue:2

    Topics: Adult; Anemia; beta-Thalassemia; Chloroquine; Deferoxamine; Female; Hepatitis C; Humans; Iron Overlo

2009
Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Clinical journal of oncology nursing, 2009, Volume: 13, Issue:5

    Topics: Anemia; Blood Transfusion; Deferoxamine; Ferritins; Humans; Iron Chelating Agents; Iron Overload; Nu

2009
Early cardiac iron overload in children with transfusion-dependent anemias.
    Haematologica, 2009, Volume: 94, Issue:12

    Topics: Adolescent; Anemia; beta-Thalassemia; Blood Transfusion; Chelation Therapy; Child; Deferiprone; Defe

2009
Iron toxicity: optimizing chelation therapy across transfusion-dependent anaemias. Introduction.
    Blood reviews, 2009, Volume: 23 Suppl 1

    Topics: Anemia; Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Humans; Iron; Iron Ove

2009
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.
    Blood, 2003, Jun-01, Volume: 101, Issue:11

    Topics: Adult; Aged; Anemia; Case-Control Studies; Chelation Therapy; Deferoxamine; Ferritins; Follow-Up Stu

2003
[PREVENTION OF HYPERACTIVE ERYTHROPOIESIS AS A THERAPEUTIC CRITERION IN THALASSEMIA AND OTHER CORPUSCULAR ANEMIAS. PRELIMINARY NOTE].
    Prensa medica argentina, 1963, Feb-15, Volume: 50

    Topics: Anemia; Blood Transfusion; Deferoxamine; Erythropoiesis; Humans; Hydroxamic Acids; Infant; Splenomeg

1963
THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    Acta haematologica, 1963, Volume: 30

    Topics: Anemia; Anemia, Macrocytic; Deferoxamine; Diabetes Mellitus; Ferritins; Hemochromatosis; Hemoglobins

1963
[TREATMENT OF IRON LOADING WITH DESFERRIOXAMINE].
    Nederlands tijdschrift voor geneeskunde, 1963, Oct-05, Volume: 107

    Topics: Adolescent; Anemia; Anemia, Hemolytic; Anemia, Macrocytic; Child; Deferoxamine; Geriatrics; Hemoside

1963
THE TREATMENT OF IRON OVERLOAD WITH DESFERRIOXAMINE B.
    Irish journal of medical science, 1964, Volume: 457

    Topics: Anemia; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Humans; Hydroxamic Acids; Iron Chelating

1964
[INFLUENCE OF DESFERRIOXAMINE ON THE URINARY ELIMINATION OF IRON IN NORMAL AND PATHOLOGICAL SUBJECTS].
    La Clinica terapeutica, 1964, Jan-31, Volume: 28

    Topics: Anemia; Deferoxamine; Duodenal Ulcer; Hemochromatosis; Humans; Hydroxamic Acids; Hypersplenism; Iron

1964
CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
    Henry Ford Hospital medical bulletin, 1964, Volume: 12

    Topics: Anemia; Anemia, Aplastic; Blood Group Incompatibility; Blood Transfusion; Deferoxamine; Hemosiderosi

1964
[THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
    Jornal do medico, 1964, Apr-25, Volume: 53

    Topics: Anemia; Anemia, Aplastic; Blood Chemical Analysis; Body Fluids; Deferoxamine; Hemochromatosis; Hydro

1964
SUBSTITUTIVE-INHIBITORY THERAPY IN CONSTITUTIONAL NON-SPHEROCYTIC ERYTHROCYTIC DISEASE.
    Acta haematologica, 1964, Volume: 31

    Topics: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Nonspherocytic; Blood Transfusion; Deferoxa

1964
[A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
    Il Policlinico. Sezione pratica, 1964, Jul-20, Volume: 71

    Topics: Anemia; Anemia, Hypochromic; Biomedical Research; Deferoxamine; Hematologic Diseases; Hemochromatosi

1964
[CONGENITAL HYPOPLASTIC ANEMIA. REVIEW AND REPORT ON A CASE TREATED WITH DESFERRIOXAMINE B].
    Ugeskrift for laeger, 1964, Jul-02, Volume: 126

    Topics: Anemia; Anemia, Aplastic; Anemia, Hypoplastic, Congenital; Deferoxamine; Humans; Hydroxamic Acids; I

1964
EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD.
    Archives of internal medicine, 1964, Volume: 114

    Topics: Anemia; Deferoxamine; Humans; Iron; Iron Overload; Pentetic Acid; Pharmacology; Toxicology; Urine

1964
[RESEARCH ON DESFERRIOXAMINE B. II. THE MECHANISM OF FERRO-CHELATION "IN VIVO" BY DESFERRIOXAMINE B].
    Haematologica, 1964, Volume: 49

    Topics: Anemia; Anemia, Hypochromic; Deferoxamine; Erythrocytes; Hemochromatosis; Ions; Iron; Iron Isotopes;

1964
[RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
    Haematologica, 1964, Volume: 49

    Topics: Anemia; Anemia, Hemolytic; Anemia, Macrocytic; Deferoxamine; Hematologic Diseases; Hemochromatosis;

1964
TREATMENT OF PRIMARY AND SECONDARY HEMOCHROMATOSIS AND ACUTE IRON POISONING WITH A NEW POTENT IRON ELIMINATING AGENT (DESFERRIOXAMINE B-DFOM).
    Nederlands tijdschrift voor geneeskunde, 1964, Aug-22, Volume: 108

    Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Macrocytic; Deferoxamine; Guinea Pigs; Heavy Me

1964
IRON DEFICIENCY ANAEMIA.
    The British journal of clinical practice, 1964, Volume: 18

    Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Deferoxamine; Drug Therapy; Hematologic Diseas

1964
[DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
    La Presse medicale, 1965, Jan-09, Volume: 73

    Topics: Anemia; Anemia, Hypochromic; Blood Transfusion; Calcium; Chelating Agents; Deferoxamine; Drug Therap

1965
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
    Journal of clinical pathology, 1965, Volume: 18

    Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami

1965
STUDIES ON DESFERRIOXAMINE IN RELATION TO THE ABSORPTION OF IRON.
    British journal of haematology, 1965, Volume: 11

    Topics: Anemia; Anemia, Hypochromic; Deferoxamine; Hemochromatosis; Hemoglobins; Intestinal Absorption; Iron

1965
IRON LOADING ANEMIA.
    Journal of the Medical Association of Georgia, 1965, Volume: 54

    Topics: Anemia; Anemia, Hypochromic; Bloodletting; Deferoxamine; Drug Therapy; Hemochromatosis; Humans; Iron

1965
CLINICAL STUDIES OF STORAGE IRON WITH DESFERRIOXAMINE.
    The New England journal of medicine, 1965, Jul-08, Volume: 273

    Topics: Anemia; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Drug Therapy; Feces; Humans; Iron; Urine

1965
Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload: an update.
    Blood, 2004, Jan-15, Volume: 103, Issue:2

    Topics: Aged; Anemia; Deferoxamine; Female; Humans; Injections, Subcutaneous; Iron Chelating Agents; Iron Ov

2004
[Bull's-Eye Maculopathy with Deferoxamine Treatment].
    Klinische Monatsblatter fur Augenheilkunde, 2004, Volume: 221, Issue:3

    Topics: Aged; Anemia; Deferoxamine; Electroretinography; Erythrocyte Transfusion; Ferritins; Fluorescein Ang

2004
Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
    Journal of medicine, 1999, Volume: 30, Issue:3-4

    Topics: Anemia; Blood Transfusion; Chemical Fractionation; Child; Chromatography, Gel; Deferoxamine; Hemochr

1999
Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670).
    European journal of haematology, 2007, Volume: 78, Issue:6

    Topics: Anemia; Blood Transfusion; Deferoxamine; Humans; Iron Chelating Agents; Primary Myelofibrosis

2007
Nature of anaemia in rheumatoid arthritis. VII. Storage of iron in rheumatoid disease.
    Annals of the rheumatic diseases, 1967, Volume: 26, Issue:6

    Topics: Adult; Anemia; Arthritis, Rheumatoid; Deferoxamine; Female; Hemoglobinometry; Humans; Iron; Male; Mi

1967
[Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    Nouvelle revue francaise d'hematologie, 1984, Volume: 26, Issue:5

    Topics: Anemia; Deferoxamine; Female; Ferritins; Hemosiderosis; Heterozygote; HLA Antigens; HLA-A3 Antigen;

1984
Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.
    British medical journal (Clinical research ed.), 1984, Oct-13, Volume: 289, Issue:6450

    Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Deferoxamine; Female; Ferritins; Humans; Iron; Male; Mid

1984
Vitamin C, desferrioxamine and iron loading anemias.
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:5

    Topics: Anemia; Ascorbic Acid; Deferoxamine; Genes, Recessive; Hemochromatosis; Humans; Intestinal Absorptio

1984
Anemia of inflammatory disease in the dog: availability of storage iron in inflammatory disease.
    American journal of veterinary research, 1981, Volume: 42, Issue:4

    Topics: Anemia; Animals; Biological Availability; Deferoxamine; Dog Diseases; Dogs; Female; Ferritins; Hemos

1981
Transfusion therapy: its role in the anemias.
    Hospital practice, 1980, Volume: 15, Issue:6

    Topics: Anemia; Blood Group Incompatibility; Blood Grouping and Crossmatching; Deferoxamine; Erythrocyte Tra

1980
Treatment of iron storage disorders.
    Drugs, 1980, Volume: 20, Issue:3

    Topics: Anemia; Deferoxamine; Hemochromatosis; Humans; Iron; Liver Cirrhosis; Porphyrias; Skin Diseases; Tha

1980
Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates.
    Biochemical pharmacology, 1994, Mar-02, Volume: 47, Issue:5

    Topics: Adenosine Diphosphate; Anemia; Animals; Antioxidants; Brain; Deferoxamine; Edetic Acid; Electron Spi

1994
Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.
    Postgraduate medical journal, 1993, Volume: 69, Issue:808

    Topics: Aluminum; Anemia; Deferoxamine; Drug Resistance; Erythropoietin; Humans; Kidney Failure, Chronic; Mi

1993
Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.
    Archives of disease in childhood, 1996, Volume: 74, Issue:4

    Topics: Adolescent; Anemia; Child; Child, Preschool; Deferoxamine; Erythrocyte Transfusion; Ferritins; Hemoc

1996
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis.
    Rheumatology international, 1996, Volume: 16, Issue:2

    Topics: Anemia; Arthritis, Rheumatoid; Chronic Disease; Deferoxamine; Dose-Response Relationship, Drug; Enzy

1996
Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
    Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:2

    Topics: Administration, Oral; Aluminum Compounds; Anemia; Animals; Bile; Chelating Agents; Deferoxamine; Kid

1997
Prolonged macrophage activation and persistent anaemia in children with complicated malaria.
    Tropical medicine & international health : TM & IH, 1998, Volume: 3, Issue:1

    Topics: Analysis of Variance; Anemia; Antimalarials; Child, Preschool; Deferoxamine; Drug Therapy, Combinati

1998
Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Colony-Forming Units Assay; Deferoxamine; Drug Synergism; Er

1999
Low dose desferrioxamine can improve erythropoiesis in iron-overload hemodialysis patients without side effects.
    Renal failure, 1999, Volume: 21, Issue:6

    Topics: Anemia; Chelating Agents; Deferoxamine; Erythropoiesis; Erythropoietin; Female; Ferritins; Humans; I

1999
Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatment of anemic patients with iron overload.
    Haematologica, 2001, Volume: 86, Issue:8

    Topics: Anemia; beta-Thalassemia; Combined Modality Therapy; Deferoxamine; Female; Humans; Injections, Subcu

2001
Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.
    Clinical science and molecular medicine, 1978, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Anemia; Ascorbic Acid; Child; Child, Preschool; Deferoxamine; Humans; Infusions,

1978
Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
    Mayo Clinic proceedings, 1978, Volume: 53, Issue:3

    Topics: Adult; Anemia; Chronic Disease; Deferoxamine; Hemochromatosis; Humans; Iron; Iron Chelating Agents;

1978
Lacoferrin in rabbit bile: its relation to iron metabolism.
    Quarterly journal of experimental physiology and cognate medical sciences, 1975, Volume: 60, Issue:2

    Topics: Anemia; Animals; Bile; Deferoxamine; Hemoglobins; Iron; Lactoferrin; Lactoglobulins; Male; Rabbits;

1975
Possible mechanisms underlying potentiating effects of iron chelators in hematopoietic response to erythropoietin.
    Nephron, 1992, Volume: 61, Issue:4

    Topics: Anemia; Deferoxamine; Drug Synergism; Erythropoietin; Hematopoiesis; Humans; Kidney Failure, Chronic

1992
[Aluminum and iron deposition in dialysis patients].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Aluminum; Anemia; Bone Diseases, Metabolic; Deferoxamine; Erythropoietin; Humans; Iron; Kidney Failu

1992
Effect of body iron stores on serum aluminum level in hemodialysis patients.
    Nephron, 1992, Volume: 61, Issue:2

    Topics: Adolescent; Adult; Aged; Aluminum; Aluminum Hydroxide; Anemia; Deferoxamine; Female; Ferritins; Huma

1992
Aluminum toxicity.
    Acta clinica Belgica, 1991, Volume: 46, Issue:2

    Topics: Aluminum; Anemia; Animals; Deferoxamine; Dementia; Disease Models, Animal; Humans; Kidney Failure, C

1991
Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Lancet (London, England), 1990, Jun-16, Volume: 335, Issue:8703

    Topics: Aluminum; Anemia; Deferoxamine; Erythropoietin; Humans; Renal Dialysis; Time Factors

1990
Case management of the anemic patient epoetin alfa: focus on aluminum management.
    ANNA journal, 1991, Volume: 18, Issue:1

    Topics: Adult; Aged; Aluminum; Anemia; Deferoxamine; Erythropoietin; Female; Humans; Kidney Failure, Chronic

1991
Aluminium interference in the treatment with recombinant human erythropoietin.
    Contributions to nephrology, 1990, Volume: 87

    Topics: Aluminum; Anemia; Deferoxamine; Drug Resistance; Erythropoietin; Humans; Recombinant Proteins; Uremi

1990
Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1990, Volume: 5, Issue:6

    Topics: Adult; Aluminum; Anemia; Deferoxamine; Erythropoietin; Humans; Middle Aged; Recombinant Proteins; Re

1990
The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1990, Volume: 16, Issue:5

    Topics: Aluminum; Anemia; Biological Availability; Deferoxamine; Erythropoiesis; Erythropoietin; Female; Hum

1990
Trace elements and complications in patients undergoing chronic hemodialysis.
    Nephron, 1990, Volume: 55, Issue:4

    Topics: Aluminum; Anemia; Deferoxamine; Female; Hematocrit; Hemoglobins; Humans; Kidney Failure, Chronic; Ma

1990
Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.
    Kidney international, 1989, Volume: 36, Issue:5

    Topics: Aluminum; Anemia; Deferoxamine; Hematopoiesis; Hemoglobins; Humans; Kidney Failure, Chronic; Prospec

1989
The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population.
    Renal failure, 1989, Volume: 11, Issue:2-3

    Topics: Aluminum; Ambulatory Care; Anemia; Biomarkers; Deferoxamine; Erythrocytes; Female; Humans; Male; Reg

1989
Iron status in patients receiving erythropoietin for dialysis-associated anemia.
    Kidney international, 1989, Volume: 35, Issue:2

    Topics: Anemia; Deferoxamine; Erythropoietin; Humans; Iron; Kidney Failure, Chronic; Recombinant Proteins; R

1989
Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium.
    Lancet (London, England), 1988, May-07, Volume: 1, Issue:8593

    Topics: Adult; Aluminum; Anemia; Deferoxamine; Erythrocyte Indices; Female; Ferritins; Hemoglobins; Humans;

1988
Desferrioxamine, anaemia, and haemodialysis.
    Lancet (London, England), 1988, Jun-18, Volume: 1, Issue:8599

    Topics: Adult; Anemia; Deferoxamine; Humans; Male; Renal Dialysis

1988
Anaemia and aluminium chelation therapy in dialysis patients.
    Lancet (London, England), 1988, Jul-23, Volume: 2, Issue:8604

    Topics: Aluminum; Anemia; Deferoxamine; Humans; Renal Dialysis

1988
Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    The Journal of laboratory and clinical medicine, 1989, Volume: 113, Issue:1

    Topics: Aluminum; Anemia; Deferoxamine; Erythrocytes; Ferritins; Humans; Peritoneal Dialysis, Continuous Amb

1989
Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1987, Volume: 2, Issue:4

    Topics: Adult; Aluminum; Anemia; Blood Transfusion; Deferoxamine; Female; Hematocrit; Hemosiderosis; Humans;

1987
Desferrioxamine improves anaemia in haemodialysis patients without aluminum or iron overload.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1988, Volume: 3, Issue:1

    Topics: Anemia; Deferoxamine; Female; Humans; Middle Aged; Renal Dialysis

1988
Effect of desferrioxamine on anaemia of haemodialysis patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1988, Volume: 3, Issue:1

    Topics: Anemia; Deferoxamine; Humans; Renal Dialysis

1988
Desferrioxamine does not improve aluminium-unrelated anaemia of haemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1988, Volume: 3, Issue:3

    Topics: Adult; Anemia; Deferoxamine; Female; Humans; Male; Middle Aged; Renal Dialysis

1988
Microcytic anemia in dialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1988, Volume: 11, Issue:4

    Topics: Aluminum; Anemia; Deferoxamine; Humans; Renal Dialysis

1988
The response of the normochromic normocytic anaemia of chronic renal failure to desferrioxamine.
    Irish journal of medical science, 1987, Volume: 156, Issue:8

    Topics: Adult; Aged; Aluminum; Anemia; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Femal

1987
Iron mobilization from isolated hepatocytes.
    The International journal of biochemistry, 1986, Volume: 18, Issue:11

    Topics: Anemia; Animals; Apoproteins; Citrates; Deferoxamine; In Vitro Techniques; Iron; Iron Radioisotopes;

1986
Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1987, Volume: 9, Issue:3

    Topics: Adult; Aluminum; Anemia; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Erythrocyte

1987
Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
    Archives of internal medicine, 1985, Volume: 145, Issue:7

    Topics: Adult; Anemia; Blood Glucose; Deferoxamine; Glucose Tolerance Test; Hemosiderosis; Humans; Iron; Iro

1985
Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
    The Journal of pediatrics, 1985, Volume: 107, Issue:5

    Topics: Aluminum; Anemia; Child; Deferoxamine; Epilepsies, Myoclonic; Humans; Kidney Failure, Chronic; Male;

1985
High-dose desferoxamine and Diamond-Blackfan anemia.
    Annals of internal medicine, 1986, Volume: 104, Issue:4

    Topics: Adolescent; Anemia; Deferoxamine; Heart Failure; Humans; Infusions, Parenteral; Thalassemia; Transfu

1986
[Siderinuria caused by deferoxamine. II. The siderinuric increment obtained by association with ascorbic acid].
    Haematologica, 1973, Volume: 58, Issue:11

    Topics: Adolescent; Adult; Aged; Anemia; Ascorbic Acid; Child, Preschool; Deferoxamine; Drug Therapy, Combin

1973
[Urinary iron after desferrioxamine. I. Effectiveness and tolerance of high doses of the drug].
    Haematologica, 1972, Volume: 58, Issue:9

    Topics: Adult; Aged; Anemia; Child, Preschool; Deferoxamine; Dose-Response Relationship, Drug; Female; Human

1972
Site of action of desferrioxamine in removing iron in normal and pathological conditions.
    Acta haematologica, 1974, Volume: 51, Issue:3

    Topics: Anemia; Animals; Brain Chemistry; Deferoxamine; Heart; Infusions, Parenteral; Iron; Iron-Dextran Com

1974
[Disorders of iron metabolism in liver patients].
    Der Internist, 1966, Volume: 7, Issue:1

    Topics: Adult; Anemia; Biopsy; Deferoxamine; Feces; Female; Hemochromatosis; Humans; Iron; Iron Isotopes; Li

1966
[Desferal S and D tests in the diagnosis of anemias].
    Lijecnicki vjesnik, 1970, Volume: 92, Issue:11

    Topics: Adolescent; Adult; Anemia; Anemia, Hemolytic; Anemia, Hypochromic; Deferoxamine; Female; Humans; Mal

1970
[Iron storage disease].
    Munchener medizinische Wochenschrift (1950), 1967, Mar-31, Volume: 109, Issue:13

    Topics: Adult; Anemia; Child; Deferoxamine; Female; Hemochromatosis; Humans; Iron; Liver Diseases; Male; Mid

1967
Evaluation of storage iron by chelates.
    The American journal of medicine, 1968, Volume: 45, Issue:1

    Topics: Anemia; Animals; Bone Marrow; Deferoxamine; Feces; Hemochromatosis; Humans; Iron; Iron Isotopes; Liv

1968
Hematological investigations in Ethiopia with special reference to a high iron intake.
    Acta medica Scandinavica, 1968

    Topics: Adolescent; Adult; Altitude; Anemia; Autopsy; Blood Sedimentation; Blood Specimen Collection; Body W

1968
The chelation of iron during intestinal absorption.
    The Journal of laboratory and clinical medicine, 1969, Volume: 74, Issue:2

    Topics: Adult; Anemia; Anemia, Hypochromic; Biological Transport; Citrates; Deferoxamine; Humans; Injections

1969
[Clinical and metabolic research on treatment with desferrioxamine B in various hemosiderotic erythrocyte diseases].
    La Clinica terapeutica, 1965, Jul-15, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Deferoxamine; Female; Hemosiderosis; Human

1965
The response of free erythrocyte protoporphyrin to pyridoxine therapy in a patient with sideroachrestic (sideroblastic) anemia.
    Blood, 1966, Volume: 27, Issue:4

    Topics: Aged; Anemia; Blood Sedimentation; Deferoxamine; Erythrocytes; Hemoglobins; Humans; In Vitro Techniq

1966